• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Considering the Patient in Pediatric Drug Development: How Good Intentions Turned Into Harm

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned Into Harm

Paperback

Business GeneralMedical Reference

ISBN10: 0128238887
ISBN13: 9780128238882
Publisher: Academic Pr Inc
Published: Nov 20 2020
Pages: 414
Weight: 1.22
Height: 0.85 Width: 6.00 Depth: 9.00
Language: English

Considering the Patient in Pediatric Drug Development: How Good Intentions Turned into Harm addresses a fundamental challenge in drug development and healthcare for young patients. In clinical trials and clinical practice, the term children is used ambiguously to confer physiological characteristics to a chronological age limit, which in reality does not exist. This book outlines why the United States (US) and European Union's (EU) regulatory authorities, pediatric academia, and the pharmaceutical industry demand, support and perform pediatric drug studies, along with the key flaws of this demand that blurs the different administrative and physiological meanings of the term child.

Also in

Business General